Alliance Resource Partners (ARLP) – ARLP Updates 2024 Guidance; Revising Estimates


Wednesday, July 31, 2024

ARLP is a diversified natural resource company that generates operating and royalty income from coal produced by its mining complexes and royalty income from mineral interests it owns in strategic oil & gas producing regions in the United States, primarily the Permian, Anadarko and Williston basins. ARLP currently produces coal from seven mining complexes its subsidiaries operate in Illinois, Indiana, Kentucky, Maryland and West Virginia. ARLP also operates a coal loading terminal on the Ohio River at Mount Vernon, Indiana. ARLP markets its coal production to major domestic and international utilities and industrial users and is currently the second largest coal producer in the eastern United States. In addition, ARLP is positioning itself as an energy provider for the future by leveraging its core technology and operating competencies to make strategic investments in the fast growing energy and infrastructure transition.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Second quarter financial results. Alliance reported second quarter EBITDA and earnings per unit (EPU) of $177.7 million and $0.77, respectively, compared to $249.2 million and $1.30 during the prior year period. We had forecast EBITDA and EPU of $196.9 million and $0.86. Revenue declined 7.6% to $593.4 million due to lower coal sales volumes, which declined 11.8% due to transportation delays that were partially offset by higher coal sales price realizations which increased 3.8% to $65.30 per ton. Alliance experienced a $3.7 million, or $0.03 per unit, decrease in the fair value of the partnership’s digital assets. Roughly 500,000 tons of coal sales were deferred and are expected to be made up during the remainder of the year.

Updated 2024 corporate guidance. Management updated its 2024 guidance which calls for lower coal sales volumes and higher oil and gas royalty volumes. The lower coal sales guidance is based on uncertainty associated with coal export sales. While the guidance for coal sales volume was lowered, sales price realization expectations were increased at the midpoint of guidance.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

CBIZ’s $2.3 Billion Acquisition of Marcum: A Game-Changer in Professional Services

Key Points:
– CBIZ to acquire Marcum in a $2.3 billion cash-and-stock deal
– Transaction will make CBIZ the seventh-largest accounting services provider in the U.S.
– Combined annual revenue expected to reach $2.8 billion post-acquisition

In a landmark move that’s set to reshape the landscape of professional services in the United States, CBIZ, Inc. (NYSE: CBZ) announced on July 31, 2024, its agreement to acquire Marcum, LLP for approximately $2.3 billion. This strategic acquisition will catapult CBIZ to the position of the seventh-largest accounting services provider in the country, with projected annual revenues of $2.8 billion.

The transaction, which is expected to close in the fourth quarter of 2024, will see CBIZ acquire Marcum’s non-attest business. Concurrently, Mayer Hoffman McCann P.C., a long-standing partner of CBIZ, will acquire Marcum’s attest business. The deal structure involves a mix of cash and stock, with about half the consideration to be paid in each form.

Founded in 1951, Marcum has established itself as a formidable player in the accounting and advisory services sector. With 43 offices across major U.S. markets and a client base exceeding 35,000, Marcum brings significant scale and expertise to the table. The firm’s annual revenue of approximately $1.2 billion and workforce of over 3,500 professionals will substantially boost CBIZ’s market presence and service capabilities.

Jerry Grisko, President and CEO of CBIZ, hailed the acquisition as “the most significant transaction in CBIZ’s history.” He emphasized the enhanced value proposition for clients, stating, “Together, we will provide a breadth of services and depth of expertise that is unmatched in our industry.”

The merger is expected to yield numerous benefits for CBIZ. It will strengthen the company’s market position in the middle market segment and accelerate growth while improving acquisition capabilities. The combined entity will be better positioned to attract and retain top talent, expand service offerings, and deepen industry expertise. Furthermore, the merger will enable increased investment in technology and innovation, potentially driving significant shareholder value, with an estimated 10% contribution to adjusted earnings per share in 2025.

Jeffrey Weiner, Chairman & CEO of Marcum, expressed enthusiasm about the merger, highlighting the shared commitment to high-quality services and the potential for leveraging combined strengths to better serve clients. He emphasized the similarities in their business models and the opportunities this merger presents for bringing more diversified services and greater subject matter expertise to their clientele.

The transaction is subject to approval by CBIZ stockholders and Marcum’s partners, along with other customary closing conditions. Both companies have engaged top-tier financial and legal advisors to facilitate the deal, underscoring the significance of this merger in the professional services landscape.

This acquisition marks a significant milestone in the professional services industry, creating a powerhouse with unparalleled reach and capabilities. As the business world continues to evolve, the combined entity of CBIZ and Marcum appears well-positioned to meet the diverse and complex needs of middle-market clients across the United States.

The market’s response to this announcement will be closely watched, as it could potentially trigger further consolidation in the professional services sector. For now, all eyes are on CBIZ and Marcum as they prepare to join forces in what promises to be a transformative union in the world of accounting and advisory services. The success of this merger could set a new standard for strategic growth and client service in the industry, potentially influencing future moves by other major players in the field.

Release – GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024

Research News and Market Data on GOVX

GeoVax to Host Conference Call at 4:30 PM ET

Atlanta, GA, July 30, 2024 – GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it will report second quarter 2024 financial results on Tuesday, August 6, 2024, after the close of U.S. markets. Following the release, management will host a live conference call and webcast, including Q&A, at 4:30 p.m. ET to provide a corporate update and discuss financial results.

Conference Call Details

Domestic(800) 715-9871

International: +1 (646) 307-1963

Conference ID: 3852178

Webcast:  https://edge.media-server.com/mmc/p/qj3e68n8

A webcast replay of the call will be available for three months via the same link as the live webcast approximately two hours after the end of the call.

About GeoVax

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.

Company Contact: Investor Relations Contact:                         Media Contact:
info@geovax.com                          austin.murtagh@precisionaq.com sr@roberts-communications.com 
678-384-7220 212-698-8696 202-779-0929

Release – Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain

Research News and Market Data on TNXP

July 30, 2024 8:00am EDT

Presentation to highlight statistically significant Phase 3 results of Tonmya™ for the management of fibromyalgia, including improvement in pain and sleep quality

Tonix granted FDA Fast Track Designation for Tonmya™; NDA submission on track for the second half of 2024

CHATHAM, N.J., July 30, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced a poster presentation at the International Association for the Study of Pain (IASP) 2024 World Congress on Pain, being held August 5-9, 2024 in Amsterdam, Netherlands. Details on the presentation can be found below.

A copy of the Company’s poster presentations will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be found on the IASP website here.

Poster Presentation Details

Presenter:Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals
Title:Targeting Fibromyalgia Non-Restorative Sleep with Bedtime TNX-102 SL (Sublingual Cyclobenzaprine HCl): Results of the Positive Phase 3 RESILIENT Trial Consistent with Syndromic Improvement
Abstract:#WE685
Date/Time:Wednesday, August 7, 2024, 3:15 p.m. CEST
  

Tonix Pharmaceuticals Holding Corp.**

Tonix is a fully-integrated biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (CNS) disorders. Tonix’s priority is to submit a New Drug Application (NDA) to the FDA in the second half of 2024 for Tonmya*, a product candidate for which two statistically significant Phase 3 studies have been completed for the management of fibromyalgia. The FDA has granted Fast Track designation to Tonmya for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, our commercial subsidiary, markets Zembrace® SymTouch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults.

*Tonmya™ is conditionally accepted by the U.S. Food and Drug Administration as the tradename for TNX-102 SL for the management of fibromyalgia. Tonmya has not been approved for any indication.

**Tonix’s product development candidates are investigational new drugs or biologics and have not been approved for any indication.

Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. All other marks are property of their respective owners.

This press release and further information about Tonix can be found at www.tonixpharma.com.

Forward Looking Statements

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements are based on Tonix’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, risks related to the failure to obtain FDA clearances or approvals and noncompliance with FDA regulations; risks related to the failure to successfully market any of our products; risks related to the timing and progress of clinical development of our product candidates; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third party payor reimbursement; limited research and development efforts and dependence upon third parties; and substantial competition. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. Tonix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024, and periodic reports filed with the SEC on or after the date thereof. All of Tonix’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date thereof.

Investor Contact

Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
(862) 904-8182

Peter Vozzo
ICR Westwicke
peter.vozzo@westwicke.com
(443) 213-0505

Media Contact

Katie Dodge
LaVoieHealthScience
kdodge@lavoiehealthscience.com
(978) 360-3151

Primary Logo

Source: Tonix Pharmaceuticals Holding Corp.

Released July 30, 2024

Release – SKYX Announces a Collaboration with Home Depot for its Advanced and Smart Plug & Play Products for both Retail and Professional Segments

Research News and Market Data on SKYX

SKYX will Offer a Variety of its Advanced and Smart Plug & Play Products including Retrofit Kits, Smart Light Fixtures, Smart Ceiling Fans, Ceiling Outlet Receptacles, Recessed Lights and More

MIAMI, July 30, 2024 (GLOBE NEWSWIRE) — SKYX (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a highly disruptive smart platform technology company with over 94 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the new standard, announced today a collaboration with world leading home improvement retailer, Home Depot, for its advanced and smart plug & play products.

SKYX will offer a variety of its Advanced and Smart Plug & Play Products including Retrofit Kits, Smart Light Fixtures, Smart Ceiling Fans, Ceiling Outlet Receptacles, and Recessed Lights among others. A large assortment of these advanced and smart products is expected to be offered on Home Depot’s website in the next coming months, while some advanced and smart plug & play retrofit kit products are expected to arrive in select stores and online to be offered as a fixture upgrade.

Steve Schmidt President of SKYX Platform said: “We are truly excited that we are collaborating with the world leading home improvement company Home Depot. Our technology offers a variety of products for both retail and professional segments; therefore, I view this collaboration as a tremendous growth opportunity for us that can have a significant impact on our business”.

Rani Kohen, Founder and Executive Chairman of SKYX Platforms, said: “We are excited to work together with Home Depot, a global leader in retail and professional industries. We strongly believe that this opportunity will have a significant effect on our business and market penetration for both our retail and professional sales channels”.

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 94 U.S. and global patents and patent pending applications. Additionally, the Company owns over 60 lighting and home decor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com/ or follow us on LinkedIn.

Forward-Looking Statements

Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws.

Investor Relations Contact:

Jeff Ramson

PCG Advisory

jramson@pcgadvisory.com

Release – Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 P.M. ET

Research News and Market Data on SHWZ

DENVER, July 30, 2024 (GLOBE NEWSWIRE) — Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), will host a conference call on Tuesday, August 13, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the second quarter ended June 30, 2024. The Company’s results will be reported in a press release prior to the call.

The Schwazze management team will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing ir@schwazze.com.

Date: Tuesday, August 13, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (844) 825-9789
International dial-in: (412) 317-5180
Conference ID: 10191294
Webcast: SHWZ Q2 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (844) 512-2921
International replay number: (412) 317-6671
Replay ID: 10191294

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTC: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit http://www.schwazze.com/.

Investor Relations Contact

Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
ir@schwazze.com

US National Debt Hits $35 Trillion: Implications and Challenges

Key Points:
– US national debt surpasses $35 trillion, growing at nearly $5 billion per day in 2025.
– Debt-to-GDP ratio reaches 120%, highest since World War II.
– Interest payments on debt now exceed defense spending.
– Political attention to the debt crisis remains limited despite its significance.

The United States has crossed a critical financial threshold as its national debt surpassed $35 trillion, according to recent Treasury Department reports. This unprecedented figure represents more than just a number; it signifies a complex economic challenge with far-reaching implications for the nation’s future, its global standing, and the financial well-being of every American citizen.

The pace of debt accumulation is alarming. Since January, the national debt has increased by $1 trillion, growing at a rate of nearly $5 billion per day in 2025. This rapid expansion has pushed the debt-to-GDP ratio to 120%, a level not seen since the aftermath of World War II. Projections from the Congressional Budget Office suggest this ratio could reach a staggering 166% by 2054 if current trends continue.

The roots of this debt crisis stretch back decades but have accelerated dramatically in recent years. Both the Trump and Biden administrations have overseen significant increases, with the debt jumping by more than 75% during their combined terms. The COVID-19 pandemic exacerbated the situation, necessitating unprecedented levels of government spending to stabilize the economy.

One of the most concerning aspects of this debt milestone is the cost of servicing it. Interest payments on the national debt have now surpassed defense spending, creating a significant drain on the federal budget. This situation threatens to crowd out funding for essential government services and investments in the nation’s future.

Despite the gravity of the situation, the issue has received surprisingly little attention in the ongoing 2024 presidential campaign. Neither presumptive Democratic nominee Vice President Kamala Harris nor former President Donald Trump have offered substantial plans to address the debt crisis. In fact, both parties are considering policies that could potentially worsen the situation, such as extending tax cuts set to expire in 2025.

The lack of political focus on this issue is particularly troubling given the looming tax debate. The expiration of major provisions from the 2017 Trump tax cuts at the end of 2025 presents both a challenge and an opportunity. Extending these cuts without offsets could add trillions more to the national debt, while allowing them to expire would effectively raise taxes on many Americans.

Economic experts and fiscal responsibility advocates are sounding the alarm. Maya MacGuineas, president of the Committee for a Responsible Federal Budget, described the situation as “reckless and unyielding,” warning that the risks and warning signs seem to be falling on deaf ears in Washington.

The implications of this debt level extend far beyond the realm of fiscal policy. High national debt can lead to reduced economic growth, lower living standards, and diminished global influence. It also leaves the country more vulnerable to economic shocks and less able to respond to future crises.

As the United States grapples with this historic debt level, it’s clear that addressing the issue will require difficult choices and bipartisan cooperation. Potential solutions may include a combination of spending cuts, revenue increases, and economic growth strategies. However, any approach will likely involve trade-offs and sacrifices that may be politically unpopular.

The $35 trillion national debt milestone serves as a stark reminder of the fiscal challenges facing the United States. As the 2024 election approaches, voters and policymakers alike must grapple with this issue and its long-term implications for America’s economic future and global standing. The decisions made in the coming years will play a crucial role in determining whether the United States can reverse this trend and ensure a sustainable fiscal path for future generations.

Xcel Brands (XELB) – A Set Up For 2025


Tuesday, July 30, 2024

Xcel Brands, Inc. 1333 Broadway 10th Floor New York, NY 10018 United States https:/Sector(s): Consumer Cyclical Industry: Apparel Manufacturing Full Time Employees: 84 Key Executives Name Title Pay Exercised Year Born Mr. Robert W. D’Loren Chairman, Pres & CEO 1.27M N/A 1958 Mr. James F. Haran CFO, Principal Financial & Accou

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

In line Q2 preliminary results. The company announced limited, preliminary operating results from Q2. Revenue in the quarter is expected to be $3.0 million, modestly below our estimate of $3.6 million, and adj. EBITDA of negative $40,000 was in line with our estimate of negative $64,000. 

LOGO sale finalized. The sale of the LOGO brand was finalized on June 30, and the company is expected to recognized a one time gain of $3.8 million. We estimate that Lori Goldstein accounted for roughly $5 million in annual revenues and $2 million in adj. EBITDA. However, after earn-outs, we estimate that the company was losing money on the brand.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Eledon Pharmaceuticals (ELDN) – Eledon Announces Patient Enrollment Milestone and Confirms Timeframe For Completion


Tuesday, July 30, 2024

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Eledon Announced It Has Reached Two-Thirds Patient Enrollment Milestone. Eledon has enrolled its 80th patient in the Phase 2 BESTOW trial testing tegoprubart against tacrolimus for prevention of kidney transplant rejection. The trial is expected to reach its full enrollment of 120 patients by YE2024 as expected.

The BESTOW Trial Is Designed To Compare Tegoprubart To Tacrolimus. The Phase 2 BESTOW trial is an open-label active-comparator trial comparing tegoprubart directly against tacrolimus, the standard of care in kidney transplantation. The primary endpoint is superior mean eGFR (a measure of kidney graft function) at 12 months post-transplant, with additional endpoints to provide clinically meaningful measures for comparison with tacrolimus.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Lundin Mining and BHP’s Joint Venture: Reshaping the Copper Mining Landscape

Key Points:
– Lundin Mining and BHP form a C$4.1 billion joint venture to acquire Filo Corp.
– The deal focuses on developing the Filo del Sol and Josemaria copper projects in the Vicuña District.
– This transaction reflects industry trends towards consolidation, copper focus, and long-term district-scale development.

The recent announcement of Lundin Mining and BHP’s joint acquisition of Filo Corp. and the formation of a 50/50 joint venture marks a significant milestone in the global mining industry, particularly in the copper sector. This C$4.1 billion deal, valuing Filo at C$33.00 per share, represents a strategic move to consolidate and develop one of the world’s most promising copper districts. At the heart of this transaction are two key projects: the Filo del Sol (FDS) copper-gold-silver deposit and the Josemaria copper project, located along the Argentina-Chile border. Together, these projects form part of the emerging Vicuña District, which has the potential to become one of the world’s largest copper mining complexes.

The deal structure is multifaceted, with Lundin Mining and BHP jointly acquiring Filo Corp. Filo shareholders have the option to receive cash, Lundin Mining shares, or a combination thereof. Concurrently, BHP will pay Lundin Mining US$690 million for a 50% stake in the Josemaria project, forming a joint venture that will control both FDS and Josemaria.

This transaction offers valuable insights into the current state and future direction of the mining sector. It exemplifies the ongoing trend of consolidation in the industry, particularly in copper mining. As easily accessible deposits become scarcer, major players are joining forces to tackle more challenging, but potentially more rewarding, projects. The significant premium paid for Filo Corp. underscores the growing importance of copper in the global economy, with the metal playing a crucial role in renewable energy and electric vehicle technologies.

The joint venture’s focus on developing the entire Vicuña District, rather than individual projects, reflects a shift towards more comprehensive, long-term approaches in mining. This strategy allows for greater operational synergies and more efficient use of infrastructure. By partnering, Lundin Mining and BHP are effectively sharing both the risks and rewards of these large-scale projects. BHP brings its extensive experience in developing major mining operations, while Lundin Mining contributes its regional expertise and the advanced stage of the Josemaria project.

The commitment to develop the projects “in accordance with sound mining principles consistent with international industry standards” highlights the increasing importance of environmental, social, and governance (ESG) factors in mining operations. This focus on sustainability and responsible mining practices is becoming a key consideration for investors and stakeholders in the industry.

The location of these projects in Argentina and Chile underscores the continued importance of South America in global copper production, despite recent political uncertainties in some countries in the region. With the potential for a “multi-generational mining district,” this deal reflects a long-term outlook in the mining sector, looking beyond current market conditions to secure resources for future decades.

As the global demand for copper continues to grow, driven by green energy transitions and technological advancements, deals of this magnitude and strategic importance are likely to become more common. The success of this joint venture could set a precedent for future partnerships in the industry, as companies seek to balance the immense capital requirements and risks associated with developing world-class deposits against the potential long-term rewards.

The mining sector, particularly in copper, is clearly entering a new era characterized by larger, more complex projects that require collaboration among major players. This deal between Lundin Mining and BHP could reshape the landscape of the global mining industry in the years to come, potentially inspiring similar collaborations and strategic partnerships. As the world increasingly turns to electrification and renewable energy, the importance of securing and developing large-scale copper resources will only continue to grow, making deals like this one crucial for meeting future global demand.

Crypto’s Political Surge: A New Frontier for Investors in the 2024 Election Landscape

Key Points:
– Political attention on cryptocurrency is growing, potentially influencing future regulations and market dynamics.
-Trump and other politicians are making pro-crypto promises, but implementation challenges remain.
– Investors should watch for policy shifts that could impact crypto markets and related investments.

As the 2024 U.S. presidential election looms, cryptocurrency has unexpectedly taken center stage, promising to reshape both the political and investment landscapes. The recent Bitcoin 2024 conference in Nashville served as a lightning rod for political attention, with figures from across the spectrum – most notably former President Donald Trump – making bold commitments to the crypto community.

Trump’s promises were sweeping: appointing a crypto Presidential Advisory Council, ousting SEC chair Gary Gensler, introducing crypto-friendly regulations, and even establishing a “strategic national bitcoin stockpile.” These pledges were echoed and amplified by other politicians, including Senator Cynthia Lummis and independent candidate Robert F. Kennedy Jr., who proposed acquiring up to 4 million bitcoins for a national reserve.

For investors, this surge in political interest signals potential seismic shifts in the regulatory environment. However, it’s crucial to approach these promises with a healthy dose of skepticism. Many proposed actions face significant legislative and legal hurdles, even in a favorable political climate.

The crypto industry’s growing political clout is evident in its fundraising prowess. FairShake, the largest crypto Super PAC, has amassed over $200 million, positioning itself as a formidable force in upcoming elections. This financial muscle could translate into increased lobbying power and potentially more favorable policies for the sector.

From an investment perspective, this political momentum could lead to several outcomes:

  1. Regulatory Clarity: A pro-crypto administration could usher in clearer regulations, potentially reducing market uncertainty and attracting more institutional investors.
  2. Market Volatility: Political developments will likely trigger significant price movements, creating both opportunities and risks for traders and investors.
  3. Mainstream Adoption: Increased political legitimacy could accelerate crypto’s integration into traditional financial systems, opening new investment avenues.
  4. Sectoral Impact: Companies in blockchain technology, cybersecurity, and fintech could see increased interest as crypto gains political traction.
  5. Global Competition: A U.S. pivot towards crypto-friendly policies could influence global crypto regulations and investments.

However, investors should remain cautious. The crypto market’s notorious volatility persists, and political promises often face significant obstacles in implementation. The recent ascension of Vice President Kamala Harris as the presumptive Democratic nominee adds another layer of uncertainty, given her undeclared stance on crypto regulation.

Bitcoin’s price action following the conference – surging above $70,000 before retreating – underscores the market’s sensitivity to political developments. Year-to-date, Bitcoin has risen over 50%, buoyed by increased institutional interest following the launch of Bitcoin ETFs.

As the election approaches, savvy investors should monitor several key areas:

  1. Proposed legislation affecting crypto regulations
  2. Appointments to key regulatory positions, especially at the SEC and CFTC
  3. Statements from major political figures on crypto policy
  4. Progress on initiatives like a national bitcoin reserve
  5. International reactions and policy shifts in response to U.S. developments

While political attention on crypto is growing, it’s important to note that widespread adoption and understanding remain limited. As Trump candidly observed, “most people have no idea what the hell it is.” This gap between political rhetoric and public comprehension presents both challenges and opportunities for investors.

For those considering crypto investments, a multifaceted approach is crucial:

  1. Diversification: Balance crypto investments with traditional assets to manage risk.
  2. Due Diligence: Thoroughly research projects and platforms before investing.
  3. Regulatory Awareness: Stay informed about evolving regulations both domestically and internationally.
  4. Technology Understanding: Grasp the underlying technology and its potential applications beyond currency.
  5. Long-term Perspective: Consider the long-term potential of blockchain technology beyond short-term price fluctuations.

As the 2024 election unfolds, the interplay between politics, regulation, and crypto markets will likely intensify. For investors, this evolving landscape presents a unique set of opportunities and risks. Those who can navigate the complex intersection of technology, finance, and politics may find themselves well-positioned in this new frontier of investing.

Remember, while the potential for high returns exists, so too does the risk of significant losses. As always, it’s crucial to approach any investment, especially in the volatile crypto space, with caution and in alignment with one’s risk tolerance and financial goals.

Release – FreightCar America, Inc. To Release Second Quarter Results On August 12, 2024

Research News and Market Data on RAIL

CHICAGO, July 29, 2024 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL), a diversified manufacturer of railroad freight cars, today announced that it will release its second quarter 2024 financial results on Monday, August 12, 2024 after the market close. The conference call and live webcast will be held on Tuesday, August 13 at 11:00 a.m. (Eastern Time), and will be available on the Investor Relations page of the Company’s website at www.freightcaramerica.com.

Investors, analysts, and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call which can be accessed at:

Event URL: https://viavid.webcasts.com/starthere.jsp?ei=1678919&tp_key=7f0a694b35

Please note that the webcast is listen-only and webcast participants will not be able to participate in the question and answer portion of the conference call. Interested parties may also participate in the call by dialing (877) 407-0789 or (201) 689-8562. Interested parties are asked to dial in approximately 10 to 15 minutes prior to the start time of the call.

An audio replay of the conference call will be available beginning at 3:00 p.m. (Eastern Time) on Tuesday, August 13, 2024, until 11:59 p.m. (Eastern Time) on Tuesday, August 27, 2024. To access the replay, please dial (844) 512-2921 or (412) 317-6671. The replay passcode is 13747591. An archived version of the webcast will also be available on the FreightCar America Investor Relations website.

About FreightCar America

FreightCar America, headquartered in Chicago, Illinois, is a leading designer, producer and supplier of railroad freight cars, railcar parts and components. We also specialize in railcar repairs, complete railcar rebody services and railcar conversions that repurpose idled rail assets back into revenue service. Since 1901, our customers have trusted us to build quality railcars that are critical to economic growth and instrumental to the North American supply chain. To learn more about FreightCar America, visit www.freightcaramerica.com.

Investor ContactRAILIR@Riveron.com

Source: FreightCar America, Inc.

Release – FAT Brands to Announce Second Quarter 2024 Financial Results On July 31, 2024

Research News and Market Data on FAT

LOS ANGELES, July 29, 2024 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”), a leading global franchising company and parent company of iconic brands including Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, Fazoli’s and 13 other restaurant concepts, today announced that the Company will host a conference call to review its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 PM ET. A press release with second quarter 2024 financial results will be issued prior to the conference call that day.

The conference call can be accessed live over the phone by dialing 1-844-826-3035 from the U.S. or 1-412-317-5195 internationally. A replay will be available after the call until Wednesday, August 31, 2024, and can be accessed by dialing 1-844-512-2921 from the U.S. or 1-412-317-6671 internationally. The passcode is 10189773. Hosting the call will be Andy Wiederhorn, Chairman, and Ken Kuick, Co-Chief Executive Officer and Chief Financial Officer.

The conference call will also be webcast live from the corporate website at www.fatbrands.com, under the “Investors” section. A replay of the webcast will be available through the corporate website shortly after the call has concluded.

About FAT (Fresh. Authentic. Tasty.) Brands

FAT Brands (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets, and develops fast casual, quick-service, casual dining, and polished casual dining concepts around the world. The Company currently owns 18 restaurant brands: Round Table Pizza, Fatburger, Marble Slab Creamery, Johnny Rockets, Fazoli’s, Twin Peaks, Great American Cookies, Smokey Bones, Hot Dog on a Stick, Buffalo’s Cafe & Express, Hurricane Grill & Wings, Pretzelmaker, Elevation Burger, Native Grill & Wings, Yalla Mediterranean and Ponderosa and Bonanza Steakhouses, and franchises and owns over 2,300 units worldwide. For more information on FAT Brands, please visit www.fatbrands.com.

Investor Relations:
ICR
Michelle Michalski
IR-FATBrands@icrinc.com
646-277-1224

Media Relations:
Erin Mandzik
emandzik@fatbrands.com
860-212-6509